Cochlear LtdCOH:ASX

57.46
0.31 / 0.54%
121.12k
3.93 %
0.9884
Close in AUDToday's changeShares traded1 year changeBeta
As of Apr 17 2014 07:11 BST.Data delayed by at least 20 minutes.

Income statement in AUD

Year on year Cochlear Ltd had revenues fall 3.37 % from 779.00m to 752.72m, though the company grew net income 133.37% from 56.80m to 132.56m. View full income statement

REVENUE
Gross margin69.01%
Net profit margin10.37%
Operating margin13.31%
NET INCOME
Return on assets9.77%
Return on equity21.29%
Return on investment13.70%

Growth rates in AUD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 2.86% and 132.86%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.

DIVIDEND PER SHARE
Div yield(5 year avg)3.33%
Div growth rate (5 year)10.93%
Payout ratio (TTM)190.82%
EARNINGS PER SHARE
EPS growth(5 years)2.38
EPS (TTM) vs
TTM 1 year ago
-50.9468

Cash flow in AUD

In 2013, cash reserves at Cochlear Ltd fell by 15.80m. However, the company earned 69.73m from its operations for a Cash Flow Margin of 9.26%. In addition the company used 50.42m on investing activities and also paid 38.86m in financing cash flows. View full cash flow statement

CASH FLOW
Cash flow per share--
Price/Cash flow per share--
CASH
Book value per share5.66
Tangible book value per share1.29

Balance sheet in AUD

Cochlear Ltd has a Debt to Total Capital ratio of 41.24%, a higher figure than the previous year's 16.35%. View full balance sheet

TOTAL ASSETS
Current ratio2.19
Quick ratio1.47
TOTAL DEBT
Total debt/total equity0.7019
Total debt/total capital0.4124
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.